Women and Lung Cancer

• Published in: Clinics in chest medicine Vol. 42; no. 3; pp. 467 - 482
• Main Author: Tanoue, Lynn T.
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01-09-2021
• Subjects: Epidermal growth factor receptor; Hormonal factors in lung cancer; Lung cancer in nonsmokers; Lung cancer in women; Lung cancer survival in women; Sex differences in lung cancer; Sex differences in lung cancer; Lung cancer survival in women; Lung cancer in nonsmokers; Epidermal growth factor receptor; Lung cancer in women; Hormonal factors in lung cancer
• ISSN: 0272-5231; 1557-8216
• DOI: 10.1016/j.ccm.2021.04.007

The world is witnessing a global epidemic of lung cancer in women. Cigarette smoking remains the dominant risk factor in both sexes, but multiple observations suggest that important sex-related distinctions in lung cancer exist. These include differences in histologic distribution, prevalence in never-smokers, frequency of activating EGFR mutations, likelihood of DNA adduct accumulation, and survival outcomes. Important questions such as whether women are more susceptible to carcinogenic effects of smoking or derive more benefit from lung cancer screening merit more study. A deeper understanding of sex-related differences in lung cancer may lead to improved outcomes for both women and men.